| Dade Behring and Premier Sign Agreement for Microbiology Instruments, Reagents |
Print this story |
Dade Behring (NASDAQ:DADE) and Premier announced that they have signed a multi-year agreement in which Premier, one of the largest group purchasing organizations ....
Dade Behring (NASDAQ:DADE) and Premier announced that they have signed a multi-year agreement in which Premier, one of the largest group purchasing organizations in the United States, has agreed to a three-year contract for Dade Behring’s MicroScan(R) microbiology instruments and reagents. This agreement is in addition to the announcement earlier this year of an agreement between Premier and Dade Behring for Dimension chemistry systems, StreamLab automation systems, Stratus(R) CS, Syva(R) Emit tests and hemostasis tests. Dade Behring is a worldwide leader in the field of diagnostics.
The extension of our microbiology business with Premier reflects the very positive partnership we have developed together through the years, said Jim Reid Anderson, Chairman, President and CEO, Dade Behring. It also ensures that Premier’s members--and their patients--have our commitment to provide them with the best clinical diagnostics to improve the quality of health care.
About Premier
Premier, Inc. is a strategic alliance in U.S. healthcare, entirely owned by more than 200 of the nation’s leading hospital and healthcare systems. These systems operate or are affiliated with nearly 1,500 hospital facilities and hundreds of other healthcare sites. Premier provides an array of resources supporting health services delivery including group purchasing for more than $17 billion annually in supplies and equipment. Other resources offered by Premier are supply chain and clinical performance improvement services and insurance programs. Premier is headquartered in San Diego, CA. with other major facilities in Chicago, IL and Charlotte, NC. Advocacy and policy offices are located in Washington, DC. For more information visit www.premierinc.com.
About Dade Behring
With 2003 revenues of more than $1.4 billion, Dade Behring is the world’s largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com.
|
| Light Up My life - Nov 17, 2004 13:9 IST |
|
With the clocks going back, millions of British workers will be heading home this evening in the dark. Depressing? Yes, but there could be a good reason for why we get the winter blues. When Jenny Simmonds had her first bout of SAD 20 years ago, the doctors said it was postnatal depression.
But then her spirits slumped again the following winter. She was depressed two years after the birth, says husband Jon. I’m no doctor, but I thought, ’this isn’t postnatal’. It happened again the next year, and the next. For 10 years we were told it was a chemical imbalance.
|
| EPCglobal US Supports FDA Initiative to Protect U.S. Drug Supply Chain from Counterfeit Drugs - Nov 17, 2004 12:28 IST |
|
Addressing significant challenges facing the health and life sciences industries, such as counterfeiting, the EPCglobal Inc(TM) Healthcare and Life Sciences Business Action Group has made the tracking and tracing of pharmaceutical pedigree a top priority in the development of Electronic Product Code(TM) (EPC) technology.
Today’s announcement by EPCglobal US, an affiliate of EPCglobal serving subscribers in the United States to help foster the adoption of the EPCglobal Network(TM) and leverage radio frequency technology (RFID) in the supply chain, comes on the heels of the U.S. Federal Drug Administration’s (FDA) announcement of a new initiative designed to protect the U.S. drug supply chain from counterfeit products.
|
| Enzon to Present at Credit Suisse First Boston Healthcare Conference - Nov 17, 2004 12:10 IST |
|
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that the company will participate in the Credit Suisse First Boston Healthcare Conference, which is being held November 17-19, 2004 in Phoenix, Arizona. Ken Zuerblis, Enzon’s chief financial officer, will give a 25-minute presentation on Wednesday, November 17, 2004 at 3:30 p.m. MST or 5:30 p.m. EST.
|
| Commercial Viability of Phosphatase Enzyme Class as Therapeutic Targets Analysed - Nov 17, 2004 11:53 IST |
|
Research and Markets (http://www.researchandmarkets.com/reports/c9232) has announced the addition of Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets to their offering.
Recently, several members of the phosphatase drug target class have been identified and classes of compounds have been screened with hits identified.
|
| ``Pass the Potatoes’’ This Holiday Season and Lose Weight - Nov 17, 2004 11:51 IST |
|
This holiday season, passing the potatoes doesn’t have to mean calorie counting and extra hours at the gym. Lately, potatoes have been a casualty in the carb-free, protein-centric diet craze, but recent clinical data shows that harnessing the power inside the potato can actually be a key component in the struggle to lose and manage weight. Video Available
|
| Current uses of Green-Fluorescent Protein in Biopharmaceutical Industry Examined - Nov 17, 2004 11:47 IST |
|
Research and Markets (http://www.researchandmarkets.com/reports/c9202) has announced the addition of A Guide to Green-Fluorescent Protein to their offering.
This resource-oriented practical Guide provides an all encompassing overview of the most important features and technological applications of Green-Fluorescent Protein and its variant forms. It seeks to describe Green-Fluorescent Protein’s usefulness in biomedical programs and applications.
|
| New findings may redirect strategies for treatment of prostate cancer - Nov 17, 2004 11:41 IST |
|
A new research study published in the November issue of Cancer Cell may have important implications for treatment of prostate cancer, the most common malignancy afflicting males in the United States. The research provides significant and somewhat surprising new information about modulation of the androgen receptor (AR), a key determinant of prostate cancer progression and an attractive target for prostate cancer therapies.
|
| Autism may be caused by brain swelling due to immune system reaction - Nov 17, 2004 11:40 IST |
|
Autism could be caused by an immune system reaction which causes the brain to swell, say researchers at John Hopkins University School of Medicine, USA. If this is so, we may one day be able to create a test for autism, and perhaps even develop treatment to prevent it.
|
| Egg donors could be paid £1,000, UK - Nov 17, 2004 11:39 IST |
|
Women who donate their eggs to infertile couples could be paid up to £1,000 under new proposals from the Human Fertilisation and Embryology Authority (HFEA).
Although the sale of gametes is illegal, the EU Tissues and Cells Directive, which comes into force from next April, says donors may receive compensation for the inconvenience of the procedure.
|
| Faith in God is down to your genes, says Researcher - Nov 17, 2004 11:38 IST |
|
Whether or not you are religious and believe in God is down to your genes, says Dean Hamer, National Cancer Institute’s Gene Structure Regulation Unit, USA. He reckons Jesus, Mohammed (the prophet) and Buddha probably carried the ‘God Gene’ in them. Church representatives have criticised Dean Hamer’s findings.
|
| Arthritis patients ’failed’ by NHS, UK - Nov 17, 2004 11:38 IST |
|
The NHS is failing to provide adequate support for those suffering with musculoskeletal conditions (MSCs), according to new research.
A study conducted by the Arthritis and Musculoskeletal Alliance (ARMA) found that many patients are being subjected to poor standards of care and provided with little support to help them deal with their condition.
|
| Charities call for smoking ban - Nov 17, 2004 11:37 IST |
|
The UK’s leading cancer charities are calling on the Government to introduce a full ban on public smoking.
Macmillan Cancer Relief, the Roy Castle Lung Cancer Foundation, the British Lung Foundation and Marie Curie Cancer Care are jointly requesting that England follow the example of Ireland and Scotland and impose an outright smoking ban in enclosed public places such as bars and restaurants.
|
| Reid denies health plans will restrict freedom, UK - Nov 17, 2004 11:36 IST |
|
The Government aims to protect public health but its plans will not restrict people’s freedom of choice, health secretary John Reid has said.
Tomorrow’s White Paper on public health is expected to suggest how to tackle the increasing problems of childhood obesity and smoking-related illnesses.
|
| Inactive form of scatter factor protein found to suppress tumor growth and spread - Nov 17, 2004 11:35 IST |
|
Scatter factor (SF) is a growth factor that controls the proliferation and survival of many tissues by promoting invasive growth in both normal and disease-related biological processes.
Produced in a precursor form, pro-SF must be cleaved in order to activate its receptor, Met tyrosine kinase.
|
| Take the Dust Mite Quiz! - Nov 17, 2004 11:34 IST |
|
To help people learn about and reduce dust mites from their homes, the American Lung Association and ProTeam, maker of high-performance vacuum cleaners, have launched a simple online quiz that will test consumers’ Dust Mite I Q.
With a time limit of 30 seconds per question, visitors quickly choose from multiple-choice answers to questions that test their knowledge about dust mite basics: where they live in your home, what they feed on, how they can affect your breathing, and how to control them. Click here to take the quiz!
|
| MS Patients Benefit from Pumping Iron - Nov 17, 2004 11:34 IST |
|
Researchers in Melbourne, Australia, have found that exercise can have significant benefits for patients with multiple sclerosis (MS), challenging the conventional medical wisdom.
Doctors normally do not recommend that patients with MS do strenuous exercise.
|
| UN Fails to Reach Compromise on Human Cloning Issue - Nov 17, 2004 11:32 IST |
|
United Nations diplomats on Thursday said that talks aimed at reaching a compromise on a proposed human cloning ban have failed and, as a result, a General Assembly panel on Friday is expected to vote on the U.S.-supported total cloning ban, Reuters reports (Arieff, Reuters, 11/11).
|
| Combination treatment helps thyroid cancer patients live longer - Nov 17, 2004 11:32 IST |
|
Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer, according to a study published in the November 15, 2004, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
|
| Good Intentions Versus Bad Habits: Why the Old Ways Win Out - Nov 17, 2004 11:31 IST |
|
Why are old habits so hard to break? A new study suggests that over time, our bad habits (such as smoking cigarettes or over eating) become automatic, learned behaviors. Even if we consciously try to put new good intentions into place, those previously learned habits remain stronger in more automatic, unconscious forms of memory.
|
| Ban on TV junk food ads - Nov 17, 2004 11:30 IST |
|
Adverts for junk foods could be banned from being shown on television before the 9pm watershed as part of a Government strategy to tackle obesity.
Sunday newspaper reports suggest that the proposal will form part of the Government’s Public Health White Paper to be published tomorrow.
|
|
|
|
|
